Rafferty Asset Management, LLC - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 124 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,059,748
-3.4%
710,258
+9.3%
0.01%
-22.2%
Q4 2022$2,131,272
-16.3%
649,778
-3.6%
0.02%
-33.3%
Q3 2022$2,547,000
-15.7%
673,779
+73.7%
0.03%
-3.6%
Q2 2022$3,022,000
-16.0%
387,937
+0.2%
0.03%
+33.3%
Q1 2022$3,596,000
-9.8%
387,085
+53.0%
0.02%0.0%
Q4 2021$3,986,000
+81.4%
252,923
+106.1%
0.02%
+40.0%
Q3 2021$2,197,000
-10.6%
122,717
-22.4%
0.02%0.0%
Q2 2021$2,458,000
-13.2%
158,097
-19.8%
0.02%
-21.1%
Q1 2021$2,831,000
+569.3%
197,137
+814.6%
0.02%
+375.0%
Q4 2020$423,000
-54.2%
21,555
-69.8%
0.00%
-63.6%
Q3 2020$924,000
+75.7%
71,329
+97.5%
0.01%
+57.1%
Q2 2020$526,000
-49.5%
36,113
-42.8%
0.01%
-56.2%
Q4 2019$1,041,000
-54.7%
63,189
-61.1%
0.02%
-55.6%
Q3 2019$2,296,000
-4.5%
162,624
+36.1%
0.04%
-14.3%
Q2 2019$2,403,000
-6.9%
119,506
+84.1%
0.04%0.0%
Q1 2019$2,580,00064,8990.04%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Antipodean Advisors LLC 1,000,000$1,480,0007.58%
Redmile Group, LLC 6,280,813$9,295,6030.44%
Arctis Global LLC 397,046$587,6280.32%
Baupost Group 9,773,616$14,4650.28%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 230,000$413,4000.24%
MAVERICK CAPITAL LTD 6,290,713$9,310,2550.21%
683 Capital Management, LLC 1,200,000$1,776,0000.14%
STALEY CAPITAL ADVISERS INC 1,000,000$1,480,0000.08%
WASATCH ADVISORS LP 8,399,229$12,430,8590.08%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 525,000$777,0000.07%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders